Hochster HS - Search Results

1

Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.

Hochster HS, Hart LL, Ramanathan RK, Childs BH, Hainsworth JD, Cohn AL, Wong L, Fehrenbacher L, Abubakr Y, Saif MW, Schwartzberg L, Hedrick E. Hochster HS, et al. J Clin Oncol. 2008 Jul 20;26(21):3523-9. doi: 10.1200/JCO.2007.15.4138. J Clin Oncol. 2008. PMID: 18640933 Clinical Trial.

2

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.

Speyer JL, Green MD, Zeleniuch-Jacquotte A, Wernz JC, Rey M, Sanger J, Kramer E, Ferrans V, Hochster H, Meyers M, et al. Speyer JL, et al. J Clin Oncol. 1992 Jan;10(1):117-27. doi: 10.1200/JCO.1992.10.1.117. J Clin Oncol. 1992. PMID: 1727913 Clinical Trial.

3

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.

Hochster HS, Kim KM, Green MD, Mann RB, Neiman RS, Oken MM, Cassileth PA, Stott P, Ritch P, O'Connell MJ. Hochster HS, et al. J Clin Oncol. 1992 Jan;10(1):28-32. doi: 10.1200/JCO.1992.10.1.28. J Clin Oncol. 1992. PMID: 1727921 Clinical Trial.

4

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

Jacobs C, Lyman G, Velez-García E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L, et al. Jacobs C, et al. J Clin Oncol. 1992 Feb;10(2):257-63. doi: 10.1200/JCO.1992.10.2.257. J Clin Oncol. 1992. PMID: 1732427 Clinical Trial.

5

Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer.

Beller U, Speyer J, Colombo N, Sorich J, Wernz J, Hochster H, Zeleniuch-Jacquotte A, Porges R, Beckman EM. Beller U, et al. J Clin Oncol. 1991 May;9(5):809-17. doi: 10.1200/JCO.1991.9.5.809. J Clin Oncol. 1991. PMID: 2016624 Clinical Trial.

6

Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.

Speyer JL, Beller U, Colombo N, Sorich J, Wernz JC, Hochster H, Green M, Porges R, Muggia FM, Canetta R, et al. Speyer JL, et al. J Clin Oncol. 1990 Aug;8(8):1335-41. doi: 10.1200/JCO.1990.8.8.1335. J Clin Oncol. 1990. PMID: 2199620

7

Combined doxorubicin/vinorelbine (Navelbine) therapy in the treatment of advanced breast cancer.

Hochster HS. Hochster HS. Semin Oncol. 1995 Apr;22(2 Suppl 5):55-9; discussion 59-60. Semin Oncol. 1995. PMID: 7740334 Review.

8

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.

Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Raphael B, Vinci RZ, et al. Hochster H, et al. J Clin Oncol. 1994 Mar;12(3):553-9. doi: 10.1200/JCO.1994.12.3.553. J Clin Oncol. 1994. PMID: 8120553 Clinical Trial.

9

Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group.

Wadler S, Haynes H, Beitler JJ, Goldberg G, Holland JF, Hochster H, Bruckner H, Mandeli J, Smith H, Runowicz C. Wadler S, et al. J Clin Oncol. 1993 Aug;11(8):1517-22. doi: 10.1200/JCO.1993.11.8.1517. J Clin Oncol. 1993. PMID: 8393097 Clinical Trial.

10

Phase II trial of carboplatin in patients with metastatic malignant melanoma. A report from the Eastern Cooperative Oncology Group.

Chang A, Hunt M, Parkinson DR, Hochster H, Smith TJ. Chang A, et al. Am J Clin Oncol. 1993 Apr;16(2):152-5. doi: 10.1097/00000421-199304000-00015. Am J Clin Oncol. 1993. PMID: 8452109 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page